Home
About
Training
Reporting
Join Us
Contact
NC HIDTA
Law Enforcement Partner
Public Safety / Govt Partner
Healthcare / Public Health Partner
Private Sector Partner
Most Recent Documents
WS-M-215-TREAT Addressing Gaps in the Addiction Specialty Workforce
- Posted 04/24/2018
PHARM-T-1230 Interprofessional Excellence Integrating Pharmacists into the MAT Team
- Posted 04/24/2018
PHARM-T-200 Community Pharmacists and Harm Reduction Evidence and Opportunities
- Posted 04/24/2018
PHARM-T-345 Pharmacy-Based Naloxone
- Posted 04/24/2018
PHARM-W-1230 Pharmacists and Physicians
- Posted 04/24/2018
PREV-W-1230 Changing Prescribing Practices to Prevent Opioid Addiction
- Posted 04/24/2018
PREV-W-345 Using EHR-Based Clinical Decision Supports to Affect Opioid Prescribing Behavior
- Posted 04/24/2018
REPLACEMENT CL-W-945 VA Data about Prescription Opioids and Overdose and Suicide Clinical Implications
- Posted 04/24/2018
replacement HER-T-1115 America's Hidden Drug Epidemic
- Posted 04/24/2018
TPP-T-1230 Health Plans Address Americas Opioid Epidemic with Evidence-Based Strategies
- Posted 04/24/2018
National Rx Drug Abuse and Heroin Summit
Enforcement
LEC-W-945 Treatment Matters Best Practices in Drug Court Rx Summit 2018
REPLACEMENT PDMP-W-345 The Intersection of Law Enforcement and Healthcare - reduced
WS-M-100 Stimulants and Opioids An Emerging Drug Threat in the Midst of the Opioid Epidemic
WS-M-215-DATA Data-Driven Initiatives to End Overdoses
WS-M-215-DEC Drug-Endangered Children How Law Enforcement, Child Protection Agencies and Schools Can Help
FED-W-345 Update from the Office of National Drug Control Policy
HER-TH-1000 Addressing the Opioid Crisis Begins at the Border
LEC-T-1115 Takeaways from the HIDTA CDC Heroin Response Strategy
LEC-T-200 Law Enforcement and Harm Reduction
LEC-T-345 WEB Changing Attitudes Law Enforcement, Public Health and Naloxone
View All
LEC-Th-1000 Best Treatment Practices in Correctional Settings From Pre-Diversion to Parole
LEC-W-1115 Correctional-Based Interventions
LEC-W-200 Expanding Access to Treatment for Justice-Involved Populations
Prevention
ADV-Th-1000 How to Talk to the Media About Heroin
ADV-W-1115 Syringe Services Programs in Rural At-Risk Areas
ADV-W-345 Gender Differences and Substance Abuse
ADV-W-945 Knowledge and Agility
FED-T-345 Hope In Action
FED-W-200 Opioid Use Disorders and the Americans with Disabilities Act
FED-W-945 SAMHSA Opioid STR
Treatment
ADV-W-200 A Parity Framework
axialHealthcare_DeFosse Atkinson Watson
CleanSlate 2018 FINAL
CL-T-1115 CDC Guideline Implementing Clinical and Practice Level Strategies
CL-T-200 Integrating Peer Support Service in the ED
CL-T-345 Safe Alprazolam Prescribing and Benzodiazepine Monitoring Program
CL-Th-1000 WEB Hospitals in Action Creating Safer Post-Operative Management
CL-W-1115 Drug Testing in Clinical Practice
CL-W-200 A Rural Primary Care Clinic_s Successful Response to the Opioid Epidemic
CL-W-345 Treating Chronic Pain in a Non-Opiate-Based Format
View All
FED-T-200 Faster Data The CDC-Funded Enhanced State Opioid Overdose Surveillance Program
FPR-T-1230 What We Wish We Had Known
FPR-T-200 Kentucky_s Comprehensive System of Care Model for Pregnant and Parenting Women with SUD
FPR-T-345 Do the Next Right Thing
FPR-W-345 Long-Term Recovery
Health IT Now Vision Session Presentation HITN NCPDP McKesson v2
HER-W-1115 Naloxone Plus
Ideal Option - opioid conference with jeff neuroscience for non scientists
Pathway- Dr. Taylor RX Summit Presentation -- Final
PDMP-T-1230 PDMP Innovations Washingtons Prescriber Feedback and Wisconsins Data Analytics
PDMP-T-200 Problematic Patterns Overlapping Opioid Benzodiazepine Prescriptions
PDMP-Th-1000 I_ve Got 99 Problems and a Centralized Medical Examiner System Isn_t One
PDMP-W-200 Implementation and Evaluation of New Mexico_s PDMP Mandate Legislation in Context
PHARM-T-1230 Interprofessional Excellence Integrating Pharmacists into the MAT Team
PHARM-T-200 Community Pharmacists and Harm Reduction Evidence and Opportunities
PHARM-T-345 Pharmacy-Based Naloxone
PHARM-W-1230 Pharmacists and Physicians
PREV-W-1230 Changing Prescribing Practices to Prevent Opioid Addiction
PREV-W-345 Using EHR-Based Clinical Decision Supports to Affect Opioid Prescribing Behavior
REPLACEMENT CL-W-945 VA Data about Prescription Opioids and Overdose and Suicide Clinical Implications
replacement HER-T-1115 America's Hidden Drug Epidemic
TPP-T-1230 Health Plans Address Americas Opioid Epidemic with Evidence-Based Strategies
TPP-T-200 WEB Heroin and Healthcare Identifying Opportunities for Intervention Prior to Overdose
TPP-T-345 Coverage of Benefits in ACA Plans
TPP-W-1230 The Lock-in Loophole
TPP-W-200 Improving the Quality of Substance Use Disorder Treatment through Payer-Driven Change
TPP-W-945 The Role of Third-Party Payers in Promoting Multi-Disciplinary Care
TREAT-T-200 Improving Addiction Outcomes Lessons from the Physician Health Program Model
TREAT-T-345 A Review of TIP _63 Medications for Opioid Use Disorder
TREAT-W-200 Buprenorphine Use and Cost Trends
TREAT-W-345 Extended-Release Naltrexone vs. Buprenorphine-Naloxone A Comparative Effectiveness Trial
TREAT-W-945 Expanding Access to OUD Treatment The Role of Telehealth
WS-M-215-MI A Public, Private Payer Partnership to Prevent Opioid Abuse and Transform Acute Care Pain Management
WS-M-215-TREAT Addressing Gaps in the Addiction Specialty Workforce
Top
